Impact of chemotherapy schedule modification on breast cancer patients: a single-centre retrospective study.

Gunasekaran, Gobi Hariyanayagam; Hassali, Mohamed Azmi Bin Ahmad; Sabri, Wan Mohd Akmal Bin Wan; Rahman, Muhammad Tahar Bin

Gunasekaran, Gobi Hariyanayagam; Hassali, Mohamed Azmi Bin Ahmad; Sabri, Wan Mohd Akmal Bin Wan; Rahman, Muhammad Tahar Bin.

Gunasekaran GH; Oncology Pharmacy, Hospital Seri Manjung, 32040 Seri Manjung, Perak, Malaysia. gobi_hari@yahoo.com.
Hassali MABA; Discipline of Social and Administrative Pharmacy School of Pharmaceutical Sciences, University Sains Malaysia, 18000, Minden, Penang, Malaysia.
Sabri WMABW; Oncology Pharmacy, Hospital Seri Manjung, 32040 Seri Manjung, Perak, Malaysia.
Rahman MTB; Surgical Department, Hospital Seri Manjung, 32040 Seri Manjung, Perak, Malaysia.

Int J Clin Pharm ; 42(2): 642-651, 2020 Apr.

Article en En | MEDLINE | ID: mdl-32185605

Asunto(s)

Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación; Neoplasias de la Mama/tratamiento farmacológico; Neoplasias de la Mama/mortalidad; Adulto; Neoplasias de la Mama/diagnóstico; Estudios de Cohortes; Esquema de Medicación; Femenino; Humanos; Persona de Mediana Edad; Estudios Retrospectivos; Tasa de Supervivencia/tendencias; Resultado del Tratamiento

Palabras clave

Breast cancer; Chemotherapy; Hazard ratio; Overall survival; Schedule modification

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Middle aged Idioma: En Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google